Saturday, 25 December 2021

Fed's Latest Move- Demise of ARKK and Innovation Stocks?

Contributed by: TheBigFatWhale


With the latest move by the Fed, where they are looking to have 3 interest rate hikes in 2022 and into reducing their balance sheet, growth stocks have not been faring well. The move by Fed is a move towards a monetary tightening policy that will drain the exodus of liquidity that has been pumped into the economy since early 2020. 


Fed Balance Sheet

Source: Tradingeconomics.com- Fed Balance Sheet


The Fed Balance sheet has more than doubled since 2020 which is a worrying sign that things are going out of control. Therefore, the indication by Fed to reduce their balance sheet is a sound and prudent move provided they are really serious about doing it. We touch on our previous article about the 6 indicators to gauge if the S&P 500 is peaking with the Fed Balance sheet as one of our concerns.

With a potential stoppage of easy money, the prospects for growth stocks could be bleak. Most of the growth or innovation stocks run on the theory that they would be wildly profitable once they are able to scale. Moreover, it is the vision for the future and it will disrupt the whole way things are done. 


Click Here to Read More:

https://thebigfatwhale.com/feds-latest-move-demise-of-arkk-and-innovation-stocks-quick-thoughts/

NFTs as an Alternative Investment?

Contributed by: TheBigFatWhale

There have been lots of hype on NFTs recently. It is not surprising given that the Beeple NFT digital art piece, " The First 5000 days" was sold for a whopping 69 million dollars. It was purchased by a Singaporean, Vignesh Sundaresan (Metakovan), who have the conviction that it would be worth a billion dollars in the future. Fun Fact: Beeple has not sold any of his digital art for more than $100 before this auction.

The origin of NFTs could be dated back to 2014 where bitcoin minted the coloured coins. In 2017, Cryptopunks and Cryptokitties was the impetus to pivot the NFTs market.

To have a feel of the prices in the digital NFTs market, you could check out the 10 most expensive digital art to date.

Considering that CryptoPunks was a project by Larva Labs to create 10000 uniquely generated characters using the Ethereum network through an algorithm. Ethereum is the second most popular blockchain after Bitcoin and has been used for commercial contracts.

They gave out all the characters for free at its launch in 2017- in the NFT world, it is called an NFT drop. Now some of them are worth millions of dollars- what a joy to be one of the frontrunners and get a character of the Cryptopunks to call our own.

 

Source: Pexels

So what exactly is NFT?

The term for it is non-fungible tokens and they are unique by themselves, that is backed by a multimedia file. It could be digital art, video, music tune, sound recording, a tweet (Jack Dorsey first tweet sold for $2.9 million) or even a blog post, etc.

The difference between an NFT and a bitcoin would be bitcoin is fungible. There is no difference between one and the other and that makes it exchangeable; Bitcoin is like digital gold. As for NFT, most of them are currently minted in the Ethereum network, it is an original token or one of its kind.

Therefore, once we buy an NFT token, it is similar to owning a baseball card or being an owner of an original painting. Scarcity brings demand and hence possibly higher prices in the future if we choose the right NFT- must have an eye to find the next Monet, Miro or Dali of the digital art world.


Click Here To Read More:

https://thebigfatwhale.com/nft-as-an-alternative-investment/ 

 

Friday, 24 December 2021

Is Grab A Worthwhile Investment?

Guest Post by: The Big Fat Whale 

UPDATE (24th Dec 21): Grab has the intention to acquire Jaya Grocers which is at a premium but it could be a good move to establish positive cash flows and sustainable earnings. From the influx of 4.5 billion dollars, acquiring profitable businesses that have synergies with their network would be the right path forward in our view.

Grab is very much part of our life if you reside in South East Asia- be it hailing a Grab taxi, ordering food from Grab food, arranging a courier service and now even catering to our insurance and financial needs. They have the title of being the SuperApp in South East Asia.

Recently, they have just launched their stock listing in Nasdaq through the merger with Altimeter Growth Corp which is a special purpose acquisition company (SPAC) valuing the deal at $40 billion. Grab raised $4.5 billion with this merger.

Truth be told, we were never interested in Grab as an investment, especially so with headlines of them losing billions per year plastered through different media outlets. Nonetheless, with this stock listing, we decided to understand the company better and see if a turnaround is in sight.

 

Grab Business Model

 

Source: Form 8k- Altimeter Growth Corp

Grab was started in Malaysia as MyTeksi in 2012 and within a span of 9 years, their business has now expanded tremendously to include 4 main categories. They are namely:

  • Mobile (Transport)
  • Deliveries (Food and Groceries)
  • Courier Express 
  • Financial Services (Fintech)

 

Their coverage now covers the 8 countries in South East Asia as illustrated from the diagram above.


Click Here to Read More:

https://thebigfatwhale.com/is-grab-a-worthwhile-investment/ 


Monday, 24 July 2017

Rowsley (Remisier King Midas Touch)



The Remisier King is waving his Midas touch yet again. His earlier moves have so far been disappointing. The solar story was full of promise with supposedly guaranteed profits seems to be now just a castle in the sky situation. Next was the Iskander grand plan which seems to have wind down given the huge oversupply situation.

Currently, Rowsley operations are mainly in the hospitality business in UK, their architect business through RSP and their real estate development in Vantage Bay Healthcare City.

With the recent deal of injecting Thomson Medical and TMC Life Sciences, could it be the winning touch for a sustainable uptrend in the stock?

Let's look at the numbers. Rowsley is going to purchase Mr Lim's stake of Thomson Medical and TMC Life Sciences at 1.9 billion sgd dollars. The takeover of Thomson Medical in 2010 was at a price of 513 million dollars and at a valuation of around 3.4X book value and 30x PE. TMC Life Sciences are currently trading at a PE of 66X.

In a Business Times article dated September 13th 2016, it was revealed that the revenue growth of Thomson Medical went up by almost a fold and assuming profits went up by the same rate. The current state of Thomson Medical should be worth close to 1 billion with the same valuation that Mr Lim took over considering the growth of their earnings. It seems to be a fair value as Raffles Medical is trading at 30x PE and 3.2x book value currently. Also, in the article, the CEO was saying if they were to list, they are able to get a valuation of 2 to 3 billion dollars but they are aiming for a 5 billion dollars valuation. I am not sure how did he get such a valuation unless they are intending to list at an inflated valuation and there are takers for it. 

Here is the article:

For TMC Life Sciences, it is trading at a PE of 66X which is even higher than IHH of 56X, so i presume Rowsley is paying a high price for this asset and Mr Lim's stake will be worth around 320 million Sgd dollars based on their current market capitalization.

Doing up the sums, a fair value for the assets could be around 1.3 billion dollars but he is injecting it in at a valuation of 1.9 billion dollars. The deal is structured by issuing 25.3 billion of Rowsley shares to Mr Lim at a price of $0.075. Given the recent decline in healthcare stocks, perhaps it was an optimal move to try to do the deal at a good valuation.

Valuation

To make things simplistic, we will assume that 1.9 billion dollars is a fair value (After my analysis, I think Rowsley overpaid thou) for the assets and assuming their current business will be trading at their book value (Around 400 million) given that it is loss making. We will have total shares of 30.5 billion excluding the warrants that will be issued with the deal. The valuation of Rowsley should be around $0.0755 (1.9 billion plus 400 million divided by 30.5 billion). Their warrants are going to be issue at exercise price of 9 cents and 12 cents for piggyback version. Currently, the price of Rowsley seems to be defying my valuation. 

As with all the Midas touches so far, the price of Rowsley have shot up tremendously and eventually came back to reality. Unless, there are further positive developments in their existing business or the profits or growth prospects of Thomson Medical are way above my estimates. My view is at best Rowsley is worth 10 to 12 cents and this valuation is consider rich.

Do take note, lots of assumptions goes into this valuation and so kindly do your own due diligence. I would term this as a trading stock at the moment and usually trading stocks do not follow fundamentals when the animal spirits are high. Do have a proper risk management in place.

Disclaimer:
The information contained in this publication is provided to you for general information only and is not intended to nor will it create/induce the creation of any binding legal relations. The information or opinions provided do not constitute investment advice, a recommendation, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person or group of persons acting on this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise.

You may wish to obtain advice from a financial adviser before making a commitment to purchase any of the investment products mentioned herein. In the event that you choose not to obtain advice from a financial adviser, you should assess and consider whether the investment product is suitable for you before proceeding to invest.

Any views, opinions, references or other statements or facts provided in this publication are personal views and shall disclaim any liability for damages resulting from errors and omissions contained.

Thursday, 9 March 2017

US Market- On a Roll?

With the US indices (Dow and S&P) scaling all time highs, the Trump presidency has led to a surprisingly positive outcome for the equity markets. In a recent seminar, I was going through the US market outlook and i summed it up through the following points:

1) Valuation
2) Quantitative Easing Ended
3) Trumpnomics
4) Debt Levels
5) Monetary Policies
6) Global Economic Conditions
7) Technical Charts 

Valuation

Firstly, valuation of the S&P index is at the higher end of their recent range (2006 to 2016) and their PE is around 22 at the moment. We are actually not far off from the high (PE:24) during the Lehman crisis in 2008. Looking at the Price to Book Ratio, we are near 3 which was last registered in 2008 before the huge crash. Last but not least, looking at the Cyclically Adjusted Price Earnings Ratio which could smooth out outliers, we are at around 30 which is the highest level comparable to the levels before the Great Depression in 1928-1930 period. It however did reach close to 45 during the Dotcom Bubble. Enclosed are supporting charts to justify my analysis. In summary, the US indices definitely do not seem like a bargain from a valuation aspect.

Source: Bloomberg S&P Historical PE Ratio 

Source: Bloomberg S&P Historical Price to Book Ratio

Source: www.multpl.com
Quantitive Easing Ended. Start of a new era?

The quantitative easing (aka fossil fuel that has been driving the Dow Jones Index up from their abyss after Lehman crisis till 2015) has since taken a back seat. Now replacing it and driving the index higher in recent times will be Trumpnomics. 
Trumpnomics (explained in 4 parts):
1) Taxes- Reduction in Corporate Tax and Repatriation Tax Consession

With reduction in corporate taxes and repatriation tax concession (Companies like Google and Apple have lots of funds stash in overseas tax haven places), it will drive up business and investment activities and hopefully led to a multiplier effect that will out weigh the reduction in tax revenues. However, my personal belief is that big corporations would not take the bait and repatriate all funds back as the regulation could easily change if Trump do not get reelected in the future and they would not want the US authorities to have full disclosure of their overseas funds.
2) Fiscal Policies- Infrastructure Spending with notable investment such as "Great Wall of America"

There have been plans to spend close to 1 trillion dollars on infrastructure ( ie. revitalize America's aging roads, bridges, railways and airports) over a 10 year period to create jobs and sustainable growth for the US economy.
3) America First- Trade Protectionist Measure to drive up sectors such as Car Manufacturing

There have been concrete plans to bring back jobs such as car manufacturing back to US and if necessary, trade tariffs to protect the industry. There are talks with corporate honchos to bring jobs and investments to America. Companies such as General Motors, Hyundai, Walmart, Bayer AG and Alibaba have already committed to step up investments in US. My own thoughts are trade protectionist measure tends to work in the short run and might not be sustainable. According to Adam Smith’s "Invisible Hand Theory", it is best to let countries focus on what they are most efficient in producing and it will lead to an increase in overall output. Rather than sprucing up industries which US does not have a competitive advantage, they should invest into skill training and migrating workers to other industries which US has an edge or the indispensable services industries.
4) Dodd Frank - To deregulate or to regulate?

There have been talks that there will be deregulation of the Dodd Frank Act which was enacted after the Lehman crisis. Dodd Frank Act has consumers’ interests at heart, this in turn made it extremely onerous for banks and thus affected their bottom-line. The talk of de-regulation had US financials rallied after Trump was elected. Nevertheless, this would be easier said than done - this can’t be just a one man show and it will need Congress' approval which would take a long time before they can come up with some consensus.
Debt Levels and Monetary Policy

Looking at Margin debt and Government debt level, the US is currently on a high note at around 500 billion dollars and 19 trillion dollars (106 percent to GDP) respectively. The highest level registered was around 120 percent during the 1940s. We are facing the passing of the lifting of the debt ceiling on March 15th which has been set at around 20 trillion dollars and if the debt ceiling is not lifted, the US government could not borrow anymore.

With such a huge debt load and inflation within control, I feel that the US Federal reserve would not be in a rush to lift interest rates aggressively as a lower interest would make it easier to pare down the debt level. Nonetheless, the guidance from Fed will be for 3 rate hikes this year. In general, lower interest rate will be good for the equities markets but a gradual increase would signify that the economy is doing well. What we do not wish to see is an aggressive hikes policy such as during the late 1990s under Greenspan period.

Source:Dshort.com

Source: CNBC
Global Economic Conditions

Global market conditions have been pretty stagnant and we are looking at around 1-2 percent growth for most regions whereby China has also slowed their growth to around the 6 percent region. Moreover with America First Policy, growth in other regions seem to remain status quo. Thus given such a backdrop, there is no real catalyst for sustainable growth Ex America regions.

Technical Charts

Looking at the Technical Charts, it certainly is a on a good uptrend and having breach their all time high of around 18,500, it seems the stage is set for further upside. Using Fibonaci projection, we could be looking at a potential target of 22,000 for Dow Jones in the near future.

Source: IT-Finance.com

In short, weighing the different factors, I will be cautiously bullish and choice entry level will around 19,500-20,000 levels and a break below 18,500 would require us to revisit our bullish thesis. However, is this going to lead to multi years of bull run? My thoughts will be that the Trump policies are pretty short term positive in nature. At this juncture, I doubt it will pan out well as protectionist measures are usually not effective in the long haul. Therefore, there might be another bullish leg but the indices seems to have priced in most of the positives at this moment.
Disclaimer:
The information contained in this publication is provided to you for general information only and is not intended to nor will it create/induce the creation of any binding legal relations. The information or opinions provided do not constitute investment advice, a recommendation, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person or group of persons acting on this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise.

You may wish to obtain advice from a financial adviser before making a commitment to purchase any of the investment products mentioned herein. In the event that you choose not to obtain advice from a financial adviser, you should assess and consider whether the investment product is suitable for you before proceeding to invest.

Any views, opinions, references or other statements or facts provided in this publication are personal views and shall disclaim any liability for damages resulting from errors and omissions contained.